Semaglutide effective for weight loss in non-diabetic adults, research suggests

A study has found that overweight or obese participants who received semaglutide alongside lifestyle interventions had a larger mean weight loss from baseline than the placebo group.
obese scales weight
Some 86% of study participants who received semaglutide lost 5% or more of their baseline body weight

Shutterstock.com

The type 2 diabetes mellitus (T2DM) drug semaglutide is effective for weight loss in non-diabetic, overweight or obese adults, when taken alongside a reduced-calorie diet and exercise, researchers have found.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated